Green light for leukaemia drug after price cut

Leukaemia drug ibrutinib is set to be approved for routine use on the NHS in England and Wales for some people with the disease.

Read more…

Advertisements
Green light for leukaemia drug after price cut

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s